Last reviewed · How we verify
Lymphoseek and VBD Sln dissection — Competitive Intelligence Brief
phase 2
Small molecule
Live · refreshed every 30 min
Target snapshot
Lymphoseek and VBD Sln dissection (Lymphoseek and VBD Sln dissection) — Maimonides Medical Center.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Lymphoseek and VBD Sln dissection TARGET | Lymphoseek and VBD Sln dissection | Maimonides Medical Center | phase 2 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Lymphoseek and VBD Sln dissection CI watch — RSS
- Lymphoseek and VBD Sln dissection CI watch — Atom
- Lymphoseek and VBD Sln dissection CI watch — JSON
- Lymphoseek and VBD Sln dissection alone — RSS
Cite this brief
Drug Landscape (2026). Lymphoseek and VBD Sln dissection — Competitive Intelligence Brief. https://druglandscape.com/ci/lymphoseek-and-vbd-sln-dissection. Accessed 2026-05-16.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab